English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Vanderbilt University
Carol Ostrow
| Jan 12, 2018
Lundbeck teams up with Vanderbilt on schizophrenia treatment
Carol Ostrow
| Nov 11, 2017
Vanderbilt developing local HIV prevention program
Carol Ostrow
| Nov 11, 2017
Mouse model may open door to fighting kidney fibrosis
Robert Hadley
| Nov 7, 2017
Flu more likely to send people in poverty to hospital, Vanderbilt study says
Kathy Adams
| Oct 29, 2017
Vanderbilt University hosting free women's salary-negotiation workshops
Carol Ostrow
| Oct 28, 2017
Vanderbilt study finds gender, dementia influence perception of pain
Mark Iandolo
| Oct 26, 2017
Vanderbilt School of Nursing associate dean studying binge drinking effects on young adults
Trending
+
Pharmaceuticals
Patient Daily
| Jun 10, 2025
Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+
Pharmaceuticals
Patient Daily
| Jun 4, 2025
Doctor on compounded medications: They 'meet individual patient needs when commercial drugs are unsuitable'
+
Pharmaceuticals
Patient Daily
| Jun 9, 2025
Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
